How much is rent in Europe's city centres, and how has it changed since 2020?
According to Eurostat, house prices increased by 27.3% between the first quarters of 2020 and 2025, while rents rose by 12.5% from June 2020 to June 2025. But this report indicates that rent increases in city centres were significantly greater than this average.
So, as of 2025, which European cities have the most expensive rents? Where are rents the most affordable? And which cities have seen the largest increases since 2020?
Athens is the cheapest, London the most expensive
In 2025, the monthly rent for a three-bedroom flat in the centre of 28 cities in Europe ranges from €1,080 in Athens to €5,088 (or £4,278) in London. European cities can be grouped into three categories based on rent levels:
Rents above €3,000
After London, the most expensive places to rent in Europe are Zurich, Geneva, and Amsterdam, all above €3,800. Swiss cities are the priciest, with rents over €4,250. Dublin, Luxembourg, Paris, Copenhagen, and Munich also have high rents, all above €3,000. These cities are major financial, political, or international centres, driving strong demand for housing.
Rents between €2,000 and €3,000
Several well-developed cities have mid-range rents between €2,000 and €3,000. Milan, Edinburgh, and Lisbon are on the higher end of this range.
Madrid, Stockholm, Berlin, Frankfurt, and Barcelona are a bit more affordable, with average rents around €2,500.
Birmingham, Brussels, Vienna, and Prague are closer to €2,100. These cities offer relatively lower living costs compared to the top tier.
Rents below €2,000
Only five European cities have average rents below €2,000. In addition to the lowest, Athens, they include Budapest (€1,225), Istanbul (€1,614), Warsaw (€1,881), and Helsinki (€1,928).
These figures show that Western and Northern Europe have the highest rents. Strong economies, high living standards, and housing shortages are key factors in these cities. Southern and Central Europe have more mixed rent levels, while Eastern and Southeastern Europe remain the most affordable.
When non-European countries are included in the report, New York stands out as an outlier with average rents of €7,676 ($8,388), while Cairo is the cheapest at just €377.
Average salaries in the city centres of Dubai and Sydney exceed €4,000. This makes them more expensive than most European cities. Rents in Toronto, Seoul, Tokyo, Moscow, and Shanghai fall into the mid-range at around €2,500.
Related
Energy, water, and waste: How much do Europeans pay for household bills?
Can you afford to live here? Europe's cities ranked by rent-to-salary ratio
Rents for a one-bedroom apartment in the centre
Rent for a one-bedroom dwelling mostly follows the same pattern as three-bedroom. However, some cities change places in the ranking. The price ratios are also different.
Still, London (€2,732 or £2,297) remains the most expensive in Europe, while Athens (€595) is the cheapest.
In general, one-bedroom apartments cost about half as much as three-bedroom ones. This share rises to 64% in Oslo and 62% in San Francisco, but drops to 37% in Seoul. That's why San Francisco surpasses London in one-bedroom rent prices globally.
Where rents increased the most
The report shows figures in US dollars, but we converted them to euros for a fairer comparison. Changes may differ when viewed in local currencies.
Between 2020 and 2025, monthly rent for a three-bedroom apartment in city centres across Europe increased by between 3% in Helsinki and 206% in Istanbul.
In general, Southern and Eastern Europe experienced the strongest rent increases. Lisbon (81%), Prague (73%), and Edinburgh (71%) followed Istanbul, each with rises of over 70%.
Rents also rose significantly in Spain—by 65% in Barcelona and 59% in Madrid. Athens and Warsaw were the other two European cities that saw just over 50% increases.
Related
Bean vs. cup: Where is the most expensive takeaway coffee in Europe?
The UK's weak economic growth and Brexit: Is the worst over?
Rent changes vary by apartment size
For a one-bedroom apartment in the city centre, the highest and lowest rent increases across Europe between 2020 and 2025 were still seen in Istanbul (191%) and Helsinki (18%). The increase in Helsinki was higher compared to that for a three-bedroom flat (3%).
In some cities, the rent increase was higher for three-bedroom apartments—such as Istanbul (15 percentage points more), Prague (23 pp), and Amsterdam (10 pp). Other cities saw greater increases for one-bedroom flats, including Milan (20 pp) and Warsaw (10 pp).
'Big cities, bigger housing costs' shows how housing prices can vary significantly within a country. For example, housing in London is 50% more expensive than the UK average.
Income levels matter when discussing rent affordability. 'Europe's cities ranked by rent-to-salary ratio' article compares average incomes with rental costs.
Solve the daily Crossword
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 minutes ago
- Yahoo
Pear Protocol Goes Live with Hyperliquid Integration and Announces $4.1M Strategic Round Led by Castle Island Ventures
London, UK, July 28th, 2025, ChainwirePear Protocol, the premier pair trading platform in crypto, has officially launched its native integration with Hyperliquid, unlocking seamless pair trading on top of the Hyperliquid perpetual orderbook. This launch coincides with the closing of a $4.1M strategic funding round led by Castle Island Ventures, with participation from Compound VC, Florin Digital and Sigil Fund. The raise comes as Pear Protocol nears $1BN in trading volume, powering over 4,000 traders with daily volumes in beta already above $5M+. 'Hyperliquid is where the best traders are, and Pear now provides the best way to pair trade on top of that liquidity,' said Huf, Founder of Pear Protocol. 'This round marks a turning point - our investors deeply understand the space, and together we're going full throttle on execution.' What This Means for Users With the Hyperliquid integration now live, traders on Pear can enjoy: Continued eligibility for any Hyperliquid Season 3 points and HyPear Points, converting into claimable $HYPE One-click entry and exit across both legs of a pair trade Limit and TWAP execution on the ratio, optimising entry and exits TP/SL logic based on the ratio for superior risk management Direct ratio charting, net funding differentials, and custom pair weighting tools Pear makes advanced strategies simple, mobile-friendly, and capital-efficient - whether you're trading HYPE/SOL or building custom ETH/BTC trades with beta-weighted logic. Strategic Use of Funds The new capital will be deployed to: Expand Pear's institutional-grade product suite Launch vaults and APIs on HyperEVM Re-launch their spot token with deeper liquidity on Hyperliquid's Spot Orderbook Accelerate user growth and talent acquisition Position Pear for long-term sustainability – including optional protocol buybacks and new revenue lines This round strategically aligns Pear Protocol with some of the most respected players in crypto venture, each bringing ecosystem reach, product insight, and long-term conviction. 'We believe Pear is building trading infrastructure for the next wave of DeFi-native professionals,' said Wyatt Khosrowshahi, Investor at Castle Island Ventures. 'They're connecting deep crypto-native liquidity with intuitive UX, timely education, and novel execution.' About Pear Protocol Pear Protocol is the leading DeFi-native pair trading terminal, enabling users to trade one token against another with high capital efficiency. With integrations across major venues including Hyperliquid, GMX and SYMMIO, Pear serves both professional retail and institutional users. Learn more at Users can follow Pear Protocol's Twitter (@pear_protocol) account for more Protocolhuf@ pear_protocol Permalink | © Copyright 2025 All rights reserved
Yahoo
4 minutes ago
- Yahoo
Tesla, Samsung, energy stocks, & European semiconductors climb
Yahoo Finance's John Hyland outlines some of the top stories on Wall Street as part of Yahoo Finance's Market Minute. Energy stocks, like Cheniere Energy (LNG) and Venture Global (VG), are moving higher on the back of the US–EU trade deal. Tesla (TSLA) stock is climbing after CEO Elon Musk announced that the company signed a $16.5 billion chip deal with Samsung ( European semiconductor companies, like ASML Holding (ASML) and STMicroelectronics (STM), are moving to the upside from both the US–EU trade deal and the Tesla–Samsung chip deal. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute. It's time for Yahoo! Finance's market minute. US stocks are trading at record highs today after the US and the EU struck a trade deal over the weekend that will see a 15% tariff imposed on goods from the European Union. US energy stocks moving higher on the back of the deal. As Trump said that the EU agreed to purchase $750 billion in American energy products and invest $600 billion in the US on top of existing commitments. EU president Ursula von der Leyen said the purchases would help reduce the bloc's dependence on Russia for natural gas. Plus, Tesla striking a $16.5 billion deal with Samsung to produce AI chips for the EV maker. CEO Elon Musk confirmed the news on X, saying Samsung's giant new Texas fab will be dedicated to making Tesla's next generation AI6 chip. And shares of European semiconductor companies getting a boost off the back of the Samsung deal and the EU US trade deal. The agreement exempts tariffs on semiconductor equipment, giving an additional boost to the sector after its two-week long slide. And that's your Yahoo! Finance market minute.
Yahoo
4 minutes ago
- Yahoo
EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say
By Bhanvi Satija (Reuters) -The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 billion as branded medicines become subject to a tariff of 15%, analysts said on Monday. The added costs could raise prices for consumers unless pharmaceutical companies take action to mitigate the impact of the tariffs, one of the analysts said. Pharmaceuticals had historically been exempt from duties. Medicines are the largest European exports to the United States by value and the EU accounts for about 60% of all pharmaceutical imports to the U.S. On Sunday, European officials said that a bilateral trade deal for an across-the-board 15% tariff included pharmaceuticals, except for some generic drugs, which would be subject to no tariffs. The U.S. has been conducting a national security investigation into the pharmaceutical sector and the industry has been bracing for separate sectoral tariffs. President Donald Trump said earlier this month, before negotiating the bilateral deal, that pharmaceutical tariffs could be as high as 200%. Some Wall Street analysts said that they do not expect additional tariffs on the EU as a result of the investigation, but others cautioned that the deal was not yet signed and that several questions remained unanswered. UBS analyst Matthew Weston said that he expects details of the trade deal to include protective measures for EU pharma exports from the U.S. investigation, especially since such measures are being discussed in negotiations with the United Kingdom and Switzerland. ING analyst Diederik Stadig also said that while tariffs on top of the 15% were not expected, even after the conclusion of the national security investigations, nothing is completely clear "until a trade deal is inked." Stadig estimates that these levies could add $13 billion to industry expenses without any mitigation strategies, and some of that could be ultimately borne by the consumer. Bernstein analyst Courtney Breen puts the additional expenses at $19 billion for the industry, but she notes that companies might be able to absorb some of the costs with the measures they have been implementing — such as stockpiling of drug products and new deals with contract researchers. Earlier this month, Sanofi said it will sell a manufacturing facility in New Jersey to Thermo Fisher, where the French drugmaker's therapies will continue to be manufactured. Roche's CEO Thomas Schinecker said last week that the company was increasing its U.S. inventories to avoid any immediate disruption from tariffs. UBS' Weston said that it was not immediately clear which generic drugs were exempted from duties under the deal, but any impact for generic drugmaker Sandoz for this year should mostly be manageable. Shares in pharmaceutical companies Sanofi, Roche and Sandoz Group all closed up between 0.5% and 1% on Monday.